Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
목요일, 9월 10

Anavex Life Sciences Corp

AVXLNASDAQ
Trade with Public
Trade with Public
$2.75
-0.10-3.51%
가까이에: Sep 8, 5:00 PM EST
$2.69
-0.16-5.63%
프리마켓: 7:00 AM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

Anavex Life Sciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Anavex Life Sciences (AVXL).

Price Target Range — 10 Quarters

Analyst Consensus — 4 Analysts

3Buy
1Hold
Consensus RatingBuy# Analysts4Avg. Consensus PT$30Upside to Avg. PT+1015.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Mar 31, 2026D. Boral CapitalJason KolbertMaintainedBuy$24
Mar 26, 2026D. Boral CapitalJason KolbertMaintainedBuy$24
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Anavex Life Sciences, Maintains $20 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $20 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Anavex Life Sciences, Maintains $24 Price Target

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $24 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Anavex Life Sciences, Maintains $24 Price Target

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $24 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Anavex Life Sciences, Maintains $24 Price Target

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $24 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Anavex Life Sciences, Maintains $24 Price Target

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $24 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Anavex Life Sciences, Maintains $20 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $20 price target.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved